ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1903

Molecular Analysis of a Skin Equivalent Tissue Culture Model System of Systemic Sclerosis Using RNA Sequencing, Epigenetic Assays, Histology, and Immunoassays

Diana M. Toledo1, Mengqi Huang2, Yue Wang2, Bhaven K. Mehta2, Tammara A. Wood3, Avi Smith4, Yolanda Nesbeth5, Irena Ivanovska6, Brock Christensen7, Patricia A. Pioli8, Jonathan Garlick4 and Michael L. Whitfield9, 1Department of Molecular & Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 2Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 3Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 4Tufts University School of Medicine, Boston, MA, 5Celdara Medical, LLC, Lebanon, NH, 6Celdara Medical, LLC, Hanover, NH, 7Geisel School of Medicine at Dartmouth, Hanover, NH, 8Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH, 9Biomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, NH

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Gene Expression, genomics, RNA, systemic sclerosis and tissue engineering

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: 4M109 ACR Abstract: Systemic Sclerosis & Rel D/Os–Basic Science (1899–1904)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: The molecular mechanisms of systemic sclerosis (SSc) have been difficult to study outside of patient samples. Mouse models often lack key features of the disease, and fibroblast cultures show inconsistent results. We have developed an innovative skin-like tissue of SSc, self-assembled Skin Equivalents (sSE), where we study fibroblast behavior in a 3D microenvironment with epithelial-dermal crosstalk and immune interaction. Here we investigate the molecular changes in SSc sSE and show that it is molecularly similar to SSc skin biopsies.

Methods: Fibroblasts were isolated from SSc patient skin (SScDF) and normal skin (NDF), expanded and seeded into transwell chambers +/- monocytes. SSc patient-derived plasma and healthy control (HC) plasma were incorporated into the culture media during the polarization period. Normal Human Keratinocytes were seeded at 3 weeks for epithelialization, and tissues were harvested after 5 weeks followed by IHC, atomic force microscopy (AFM), RNA-seq, DNA methylation, and ATAC-seq. Cell supernatants were used for multiplex ELISA analysis.

Results: We created 136 samples of sSE from one SScDF line and one NDF line. H&E staining of SScDF sSE showed increased dermal thickness and stiffness compared to NDF sSE (Fig 1A). Differential expression of the SScDF sSE and NDF sSE with autologous plasma and monocytes showed increased expression of genes representing pathways involved in inflammatory/immune system response, myeloid-mediated immunity, myeloid cell activation, and leukocyte differentiation (Fig 1B). The upregulated genes in NDF sSE showed typical pathways involved in epithelial proliferation, tissue morphogenesis, and cell growth. Differential expression of the SScDF sSE +/- monocytes found that sSE tissues with monocytes had increased immune response, immune cell proliferation and activation, macrophage migration, and cell chemotaxis. In samples without monocytes, epithelial cell differentiation and collagen processes were upregulated, but the strong immune signal was missing. Additionally, IL6 and IL13 production increased in SScDF supernatant during tissue development and after the polarization period. Also, analysis of gene expression in SScDF sSE by RNA-seq data demonstrated molecular similarity to human SSc patient skin samples and NDF clustered more closely with HC skin samples (Fig 1C). Lastly, 3D sSE tissues and 2D monolayer fibroblast cultures have distinct DNA methylation patterns.

Conclusion: There is a hierarchy of drivers in the creation of 3D tissues, with the origin of dermal fibroblasts being the biggest modifier of disease morphology and the addition of monocytes being the next biggest factor in developing the immune response. These 3D sSE tissues consistently replicate the molecular pathways found in SSc skin and allow for a controlled model system of SSc to manipulate and test drug therapy responses.


Disclosure: D. M. Toledo, None; M. Huang, None; Y. Wang, None; B. K. Mehta, None; T. A. Wood, None; A. Smith, None; Y. Nesbeth, Celdara LLC, 3; I. Ivanovska, Celdara LLC, 3; B. Christensen, None; P. A. Pioli, None; J. Garlick, None; M. L. Whitfield, Celdara LLC, 4.

To cite this abstract in AMA style:

Toledo DM, Huang M, Wang Y, Mehta BK, Wood TA, Smith A, Nesbeth Y, Ivanovska I, Christensen B, Pioli PA, Garlick J, Whitfield ML. Molecular Analysis of a Skin Equivalent Tissue Culture Model System of Systemic Sclerosis Using RNA Sequencing, Epigenetic Assays, Histology, and Immunoassays [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/molecular-analysis-of-a-skin-equivalent-tissue-culture-model-system-of-systemic-sclerosis-using-rna-sequencing-epigenetic-assays-histology-and-immunoassays/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/molecular-analysis-of-a-skin-equivalent-tissue-culture-model-system-of-systemic-sclerosis-using-rna-sequencing-epigenetic-assays-histology-and-immunoassays/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology